Ava Shamban, MD
Dermatology · Santa Monica, CANPI 1003922162
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by AbbVie at 53.8% of the total. Reporting peaked in 2020 at $50,976 and has fallen 77.3% since, to $11,581 in 2025. Among dermatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 486 payments — averaging $420.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$110K
- Merz North America, Inc.$42K
- Revance Therapeutics, Inc.$19K
- Galderma Laboratories, L.p.$12K
- Dermira, Inc.$10K
- Solta Medical, A Division Of Bausch Health US, LLC$3K
- plus $9K from 27 others
Across 169 payments — averaging $8165.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1.1M
- Merz North America, Inc.$181K
- Galderma Laboratories, L.p.$111K
What the payments were for
- Consulting fees$122,57460%
- Speaking & faculty fees$11,7576%
- Travel & lodging$36,72118%
- Food & beverage$33,19116%
- Education$2390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 219 | $109,922 |
| Merz North America, Inc. | 58 | $42,086 |
| Revance Therapeutics, Inc. | 29 | $19,366 |
| Galderma Laboratories, L.p. | 97 | $11,596 |
| Dermira, Inc. | 4 | $9,887 |
| Solta Medical, A Division Of Bausch Health US, LLC | 7 | $3,005 |
| Osmotica Pharmaceutical Corp. | 1 | $2,975 |
| Endo Pharmaceuticals Inc. | 7 | $2,853 |
| Botanix SB Inc | 2 | $1,009 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $292 |
| Arcutis Biotherapeutics, Inc. | 4 | $290 |
| Incyte Corporation | 8 | $263 |
| Sun Pharmaceutical Industries Inc. | 8 | $184 |
| Almirall LLC | 4 | $126 |
| LEO Pharma Inc. | 4 | $72 |
| EPI Health, LLC | 4 | $56 |
| UCB, Inc. | 1 | $50 |
| Pfizer | 3 | $49 |
| Dermavant Sciences, Inc. | 2 | $47 |
| VYNE Pharmaceuticals Inc. | 2 | $45 |
| Mayne Pharma Commercial LLC | 2 | $40 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $37 |
| Amgen | 1 | $34 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $31 |
| Biofrontera Inc. | 1 | $26 |
| Sandoz | 1 | $25 |
| Mindera Corp | 1 | $22 |
| DUSA Pharmaceuticals, Inc. | 1 | $22 |
| Mission Pharmacal Company | 1 | $19 |
| Johnson & Johnson | 1 | $19 |
| Encore Dermatology Inc. | 1 | $15 |
| Medline Industries LP | 1 | $14 |
| Journey Medical Corporation | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$204,482 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 14 | $17,285 |
| Clobetasol Propionate | 12 | $562 |
| ValacyclovirValacyclovir Hcl | 25 | $422 |
| Ketoconazole | 25 | $383 |
| Triamcinolone Acetonide | 23 | $201 |
| Mupirocin | 14 | $91 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Santa Monica
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
- Tina BhutaniSan Francisco$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.